本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lakewood-Amedex Biotherapeutics (Direct Listing)

2.13
-0.1100-4.91%
盘后2.200.0700+3.29%16:47 EDT
成交量:3.95万
成交额:8.60万
市值:504.75万
市盈率:-0.21
高:2.29
开:2.20
低:2.10
收:2.24
52周最高:98.20
52周最低:1.66
股本:236.97万
流通股本:141.56万
量比:0.53
换手率:2.79%
股息:- -
股息率:- -
每股收益(TTM):-10.2000
每股收益(LYR):-8.3987
净资产收益率:-402.84%
总资产收益率:-139.40%
市净率:1.17
市盈率(LYR):-0.25

数据加载中...

2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

重要事件披露

Form 8-K - Current report
2026/06/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/17

重要事件披露

Form 8-K - Current report
2026/05/22

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

SEC问询函

Form CORRESP - Correspondence
2026/05/01

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/03/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/09

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933